Building Safer Systems for Bleeding and Clotting Care with Dr. Toyosi Onwuemene
Toyosi Onwuemene, Associate Professor with tenure Duke University School of Medicine, shared a Nneka Unachukwu’s post on LinkedIn:
“After more than two decades in academic medicine, I stepped into entrepreneurship.
It was time to stop waiting and start building.
It was time to move beyond incremental fixes.
It was time for a new strategy.
Because bleeding and clotting safety is a systems challenge.
And systems challenges demand systems solutions.
Today, I’m proud to announce CoagCoach Advisory.
CoagCoach Advisory partners with health systems, industry, and innovators to build safer systems for bleeding and clotting care.
What if we stopped waiting for someone else to build the future we need?
What if we built it ourselves, one community at a time?”
Nneka Unachukwu, Founder and CEO of EntreMD, shared a post on LinkedIn:
“Patients were waiting months. The physicians treating them were waiting too.
Early in her career as an academic hematologist, Dr. Toyosi Onwuemene kept seeing the same delay play out.
Procedures cancelled.
Surgeries pushed.
Treatment plans stalled, all while everyone waited on specialist input that took weeks or months to arrive.
Over time she realized something about what those physicians actually needed.
They were not looking for more appointments. They wanted expert guidance so they could decide.
That distinction is the whole business.
She calls herself a bleeding and clotting strategist.
Through Coag Coach, she helps physicians, surgeons, and proceduralists solve complex bleeding, clotting, and high-risk blood thinner cases in minutes.
She shows up wherever those decisions are being made, so doctors can move forward safely and patients get timely care.
What EBS changed was where her attention went.
As an employed physician, she was surrounded by people who spent their time talking about what was broken.
At EBS, she is surrounded by physicians who believe problems should be solved.
They create, they experiment, they move forward.
She is precise about the shift.
Instead of asking why is this happening, she asks what else is possible and how can this problem be solved.
That change in question is what expanded everything she has built since, for physicians, for patients, and for her family.
Her first business win was a $12,000 coaching contract.
Coag Coach has since passed 250,000 views across more than 70 countries.
The wins she leads with are not those. More time with her children.
More time with her husband.
More flexibility to be present.
And a change in how she sees herself, where she knows more is possible and leans into the value she creates without apology.
There is one more she names, and it is the one that lasts longest.
It shows her children, and the next generation, that they can do things differently and still succeed.
Her word to the physician wondering if they can: when you are surrounded by people doing the impossible, anything is possible.
Dr. Onwuemene is looking for one introduction.
A physician, practice, or surgery center that could use rapid access to bleeding and clotting expertise.
60 physicians. 60 stories. 60 days. This is Day 26.”
Stay updated with Hemostasis Today.
-
Aug 5, 2026, 23:46Recommended ESC Congress Sessions for the ESC Working Group on Thrombosis
-
Aug 5, 2026, 23:36Heghine Khachatryan: ISTH Day 2 – Phase III VAYHIT2 Data Highlights Ianalumab in Primary ITP
-
Aug 5, 2026, 23:28Basyouni Omran: KDIGO 2025/2026 Bedside Guide – Iron Correction in CKD
-
Aug 5, 2026, 23:13C. Michael Gibson: Jean Connors on Antithrombotic Therapy for LVAD at Baim Grand Rounds
-
Aug 5, 2026, 21:19Vidhi Shukla: Anticoagulant Activity of Ficus Racemosa Bark Extract in Rats
-
Aug 5, 2026, 20:30Denis Oduor: Patient Blood Management and Systemic Transfusion Reform
-
Aug 5, 2026, 20:15Salih Ehsan: Diagnostic Screening Strategy for Hemoglobinopathy Traits
-
Aug 5, 2026, 19:39Platelet-Derived Extracellular Vesicles for Hemostasis and Bleeding Reduction in TBI – Every Labs
-
Aug 5, 2026, 19:05Alfonso J. Tafur: Thromboinflammation and Hemostatic Dysfunction as Predictors of Early Pulmonary Embolism Mortality